Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced 20 March 2019
Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care 31 January 2019
Wound Care: new clinical data show Nexodyn® AOS To reduce reinfections and healing time in diabetic foot ulcers 31 January 2019
RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA® 20 December 2018
Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US 12 December 2018
Linkedin